Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 8834826)

Published in Allergy on December 01, 1995

Authors

I Fajac1, G Braunstein, M R Ickovic, J Lacronique, N Frossard

Author Affiliations

1: Service de Physiologie, UFR Cochin-Port-Royal, Paris, France.

Articles by these authors

Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) (1999) 2.11

What internists need to know: core competencies in women's health. ABIM Subcommittee on Clinical Competence in Women's Health. Am J Med (1997) 1.55

Do nasal mast cells release histamine on stimulation with substance P in allergic rhinitis? Clin Exp Allergy (1994) 1.42

Performance on the internal medicine second-year residency in-training examination predicts the outcome of the ABIM certifying examination. J Gen Intern Med (1994) 1.41

Pulmonary histiocytosis X. Am Rev Respir Dis (1978) 1.28

Neurogenic mechanisms in bronchial inflammatory diseases. Allergy (2004) 1.22

The nerve growth factor and its receptors in airway inflammatory diseases. Pharmacol Ther (2007) 1.16

Arachidonic acid metabolites and airway epithelium-dependent relaxant factor. J Pharmacol Exp Ther (1987) 1.13

Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells. Am J Respir Cell Mol Biol (1996) 1.09

Sodium-potassium ATPase, calcium, and immunological histamine release. Biochem Pharmacol (1983) 1.07

[Multifocal epithelioid hemangioendothelioma with partial remission after interferon alfa-2a treatment]. Ann Dermatol Venereol (1994) 1.07

Evidence for multidrug resistance-1 P-glycoprotein-dependent regulation of cellular ATP permeability. J Membr Biol (2001) 1.04

Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer. J Natl Cancer Inst (1986) 1.02

Epithelial modulation of tracheal smooth muscle response to antigenic stimulation. J Appl Physiol (1985) (1986) 1.01

Sodium-potassium ATPase inhibition potentiates compound 48/80-induced histamine secretion from mast cells. Br J Pharmacol (1984) 1.01

Dose-dependent effects of endotoxins on allergen sensitization and challenge in the mouse. Clin Exp Allergy (2004) 1.00

Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction. Br J Pharmacol (1981) 1.00

Twenty-four hours of activity of cetirizine and fexofenadine in the skin. Ann Allergy Asthma Immunol (2001) 0.99

Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases. Thorax (1982) 0.97

Inhaled substance P induces activation of alveolar macrophages and increases airway responses in the guinea-pig. Neuropeptides (1993) 0.95

Nerve growth factor levels and localisation in human asthmatic bronchi. Eur Respir J (2002) 0.93

Human bronchial smooth muscle cells in culture produce stem cell factor. Eur Respir J (1999) 0.92

Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis. Am Rev Respir Dis (1991) 0.92

New insights into the second generation antihistamines. Drugs (2001) 0.91

Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction. Mol Pharmacol (1988) 0.89

Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations. J Nucl Med (1991) 0.88

Calcium dependent modulation of histamine release from mast cells by sodium and potassium. Agents Actions (1985) 0.88

Pulmonary lymphangiomyomatosis. Follow-up and long-term outcome with antiestrogen therapy; a report of eight cases. Chest (1992) 0.87

Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2. J Pharmacol Exp Ther (1992) 0.87

[The bronchorelaxant effect of helicidine, a Helix pomatia extract, interferes with prostaglandin E2]. Pathol Biol (Paris) (1999) 0.87

Upregulation of nerve growth factor expression by human airway smooth muscle cells in inflammatory conditions. Eur Respir J (2002) 0.87

Up- and down-regulation by glucocorticoids of the constitutive expression of the mast cell growth factor stem cell factor by human lung fibroblasts in culture. Mol Pharmacol (1998) 0.86

In vitro bronchial hyperresponsiveness after lung transplantation in the rat. Am J Physiol (1992) 0.86

Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose. Clin Exp Allergy (2001) 0.85

Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids. Eur Respir J (2001) 0.85

Evidence for in vitro expression of B1 receptor in the mouse trachea and urinary bladder. Br J Pharmacol (1999) 0.85

Serum eosinophil cationic protein measurements in the management of perennial and periodic asthma: a prospective study. Eur Respir J (1998) 0.84

Evaluation of cytotoxicity of new semi-fluorinated amphiphiles derived from dimorpholinophosphate. Biomaterials (2003) 0.84

Nasal effect of cetirizine and loratadine at 24 hours in patients with allergic rhinitis. Am J Ther (1998) 0.83

Multiple markers for lung cancer diagnosis: validation of models for localized lung cancer. J Natl Cancer Inst (1988) 0.83

Calcium-phosphate-adjuvanted allergens: total and specific IgE levels before and after immunotherapy with house dust and Dermatophagoides pteronyssinus extracts. Ann Immunol (Paris) (1984) 0.83

Local cellular and humoral responses to antigenic and distilled water challenge in subjects with allergic rhinitis. Am Rev Respir Dis (1988) 0.82

Effect of glucocorticoids on stem cell factor expression in human asthmatic bronchi. Clin Exp Allergy (2006) 0.81

Activation of the lung S1P(1) receptor reduces allergen-induced plasma leakage in mice. Br J Pharmacol (2009) 0.81

Repeated inhalation of low doses of cat allergen that do not induce clinical symptoms increases bronchial hyperresponsiveness and eosinophil cationic protein levels. Int Arch Allergy Immunol (1999) 0.81

Modulation by theophylline and enprofylline of the excitatory non-cholinergic transmission in guinea-pig bronchi. Eur Respir J (1992) 0.80

Nerve growth factor secretion by human lung epithelial A549 cells in pro- and anti-inflammatory conditions. Eur J Pharmacol (2001) 0.80

Consistency and efficacy of cetirizine (10 mg) versus ebastine (20 mg) at 4 h on skin reactivity. Eur J Clin Pharmacol (1999) 0.80

Bronchial gamma delta T-lymphocytes and expression of heat shock proteins in mild asthma. Eur Respir J (1997) 0.80

Adenosine reduces airway excitatory non-cholinergic (e-NC) contraction through both A1 and A2 adenosine receptor activation in the guinea pig. Fundam Clin Pharmacol (1997) 0.79

Terbutaline powder in asthma exacerbations. Arch Dis Child (1991) 0.78

Cytogenetic characterization of renal cell carcinoma in von Hippel-Lindau syndrome. Cancer (1990) 0.78

[Nerve growth factor (NGF) in inflammation and asthma]. Rev Mal Respir (2004) 0.78

Silver/silver chloride electrodes for measurement of potential difference in human bronchi. Thorax (1998) 0.78

Altered expression of lung cytochrome P450 3A1 in rat after exposure to sulfur mustard. Pharmacol Toxicol (2001) 0.78

Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study. Eur Respir J (2012) 0.78

In vivo evaluation of a reverse water-in-fluorocarbon emulsion stabilized with a semifluorinated amphiphile as a drug delivery system through the pulmonary route. Int J Pharm (2004) 0.78

Inhalation of toluene diisocyanate affects cytochrome P450 2B1 expression in rat lung. Arch Toxicol (2000) 0.78

Inhibition of histamine-induced nasal obstruction by cetirizine in allergic rhinitis. Br J Clin Pharmacol (1992) 0.78

Difference in exposure to airborne major rat allergen (Rat n 1) and to endotoxin in rat quarters according to tasks. Clin Exp Allergy (2001) 0.78

The significance of 1-131 scan dose in patients with thyroid cancer: determination of ablation: concise communication. J Nucl Med (1981) 0.78

The stem cell factor, its properties and potential role in the airways. Pulm Pharmacol Ther (2001) 0.78

Effect of immunostimulation with the Corynebacterium granulosum derived immunomodulator P40 on patients with recurring respiratory infections. J Asthma (1984) 0.78

Anti-proliferative effect of Euphorbia stenoclada in human airway smooth muscle cells in culture. J Ethnopharmacol (2006) 0.77

[Primary pulmonary lymphoma on a cicatrix]. Presse Med (1985) 0.77

Phenotypic and quantitative changes in mast cells after syngeneic unilateral lung transplantation in the rat. Clin Sci (Lond) (1996) 0.77

Cushing's syndrome due to ectopic proopiomelanocortin gene expression by islet cell carcinoma of the pancreas. Cancer (1987) 0.77

Calcitonin gene-related peptide-immunoreactive nerves and neuroendocrine cells after lung transplantation in the rat. Am J Respir Cell Mol Biol (1999) 0.77

[Randomized evaluation of two teaching methods using aerosol dosers]. Rev Mal Respir (1991) 0.76

Genotype-phenotype relationships in a cohort of adult cystic fibrosis patients. Eur Respir J (1996) 0.76

Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis. Allergy (1997) 0.76

Calcium phosphate adjuvanted allergens. Ann Allergy (1985) 0.76

Effect of toluene diisocyanate and its corresponding amines on viability and growth of human lung fibroblasts in culture. Cell Biol Toxicol (1999) 0.76

Inhibition of substance P-induced microvascular leakage by inhaled methoxamine in rat airways. Br J Pharmacol (1994) 0.75

Inhibition of antigen-induced histamine release from rat mast cells by a cyclic GMP-phosphodiesterase inhibitor and sodium nitrite. Agents Actions (1981) 0.75

Testosterone therapy in women: a review. Int J Impot Res (2005) 0.75

Seasonal increase of spontaneous histamine release in washed leucocytes from rhinitis patients sensitive to grass pollen. Clin Exp Immunol (1990) 0.75

Potential anti-anaphylactic activity of clenbuterol, a beta-agonist with calcium antagonist properties. Agents Actions (1985) 0.75

Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h. Br J Clin Pharmacol (2002) 0.75

Bronchial responses to substance P after antigen challenge in the guinea-pig: in vivo and in vitro studies. Mediators Inflamm (1992) 0.75

5-HT2-mediated bronchial responses after syngeneic lung transplantation in the rat. Br J Pharmacol (1995) 0.75

Expression of tyrosine hydroxylase and neuropeptide tyrosine in mouse sympathetic airway-specific neurons under normal situation and allergic airway inflammation. Clin Exp Allergy (2004) 0.75

Calcium homeostasis during coronary bypass surgery. Circulation (1980) 0.75

[Inhaled corticosteroids in the treatment of asthma]. Allerg Immunol (Paris) (1987) 0.75

[Bioclinical conference in pneumology. Hôpital Laennec. Case no. 3--January 1985. Pulmonary opacity and infectious syndrome resistant to non-specific antibiotic treatment]. Rev Pneumol Clin (1986) 0.75

[Symptomatology of diffuse interstitial fibrosis]. Rev Prat (1980) 0.75

[Hydatid cyst of the heart. Apropos of 9 cases]. Arch Mal Coeur Vaiss (1977) 0.75

[Inhaled corticotherapy sparing effect by sodium nedocromil in moderate to severe asthma]. Rev Mal Respir (1994) 0.75

[Research on inflammatory mediators in asthma: new therapeutic approaches]. Therapie (2000) 0.75

[Orientation of radiography of the thorax]. Rev Pneumol Clin (1989) 0.75

Insulin receptors and placental proteins in normal and gestational-diabetic pregnancies. Biol Res Pregnancy Perinatol (1984) 0.75

Isoproterenol activation of prostaglandin production in guinea-pig airway muscle preparations from immature and mature animals. Prostaglandins (1991) 0.75

Photodynamic therapy of choriocarcinoma transplanted to the hamster cheek pouch. I. Intraperitoneal photosensitization. Gynecol Oncol (1990) 0.75

[Bioclinical conference in pneumology. Hôpital Laënnec. Case n. 4--February 1985. Interstitial pneumopathy associated with pulmonary infiltration by foamy macrophages]. Rev Pneumol Clin (1986) 0.75

[Mechanisms of asthma. II. Potential pharmacological targets]. Poumon Coeur (1982) 0.75

[Peripheral intra-pulmonary lymph nodes. A new clinical case]. Rev Pneumol Clin (1989) 0.75

[Effects of tobacco smoke on bronchoalveolar cells in man (author's transl)]. Bull Eur Physiopathol Respir (1981) 0.75